ANI Pharmaceuticals Inc
ANIPHealthcare|Drug Manufacturers - Specialty & Generic|USA
$82.07
-1.68 (-2.01%)
DCF (FCF)
$45.65
Tangible Book
$1.43
Graham Number
$13.56
Upcoming Data Readouts (2)
Jul 2026
Est. completion
P4Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.
NCT06539481n=25
Aug 2027
Est. completion
P4Gout Arthritis
Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares
NCT07346079n=150
Awaiting Results (3)
Trials past primary completion date but still active — data readout may be imminent.
Nov 2025
P4
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
NCT05322070Aug 2025
NA
Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial
NCT07121634Dec 2024
P4
A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
NCT04469595